If you have not already registered for Full Text Access to The Journal, then visit our registration page.
Many supplements are available to the general public for a limited time on our SuppleNet page.


VOLUME 62   2001   SUPPLEMENT 1

Advances and Emerging Treatments in Social Phobia

3 Disclosure Statements.
[PDF]

4 Introduction: Advances and Emerging Treatments in Social Phobia. Jonathan R. T. Davidson
[PDF]

5 Social Phobia: Prevalence and Diagnostic Threshold. Ariel J. Lang and Murray B. Stein
[Abstract] [PDF]

11 Social Anxiety Disorder: An Unrecognized Problem in Primary Care. David J. Katzelnick and John H. Greist
[Abstract] [PDF]

17 Social Anxiety Disorder: Comorbidity and Its Implications. R. Bruce Lydiard
[Abstract] [PDF]

25 Social Phobia: Etiology, Neurobiology, and Treatment. Nicholas J. Coupland
[Abstract] [PDF]

36 Current Status of Psychotherapeutic Interventions for Social Phobia. Richard G. Heimberg
[Abstract] [PDF]

43 Treatment of Social Phobia With Antidepressants. Franklin R. Schneier
[Abstract] [PDF]

50 Benzodiazepines and Anticonvulsants for Social Phobia (Social Anxiety Disorder). James W. Jefferson
[Abstract] [PDF]

54 Posttest.
[PDF]

56 Continuing Medical Education Program Evaluation.
[PDF]

Each article is followed by a question and answer session excerpted from the discussion that took place at the symposium "Advances and Emerging Treatments in Social Phobia."